Created at Source Raw Value Validated value
Aug. 2, 2022, 4:30 p.m. usa

None

None

Feb. 12, 2022, 3:30 p.m. usa

to covbird any medical disease or condition that, in the opinion of the site principal investigator or sub-investigator, precludes study participation significant behavioral disturbances previous diagnosis of hepatitis b, hepatitis c or hiv acute illness, with or without fever within 72 hours prior to each vaccination history of hypersensitivity or severe allergic reaction to a component of the vaccine or to a previous vaccine immunoglobulin therapy or blood products during the previous month to receive an mrna vaccine - history of myopericarditis to receive a viral vector-based vaccine prior history to vaccine-induced immune thrombotic thrombocytopenia prior history of heparin-induced thrombocytopenia prior history of capillary leak syndrome

to covbird any medical disease or condition that, in the opinion of the site principal investigator or sub-investigator, precludes study participation significant behavioral disturbances previous diagnosis of hepatitis b, hepatitis c or hiv acute illness, with or without fever within 72 hours prior to each vaccination history of hypersensitivity or severe allergic reaction to a component of the vaccine or to a previous vaccine immunoglobulin therapy or blood products during the previous month to receive an mrna vaccine - history of myopericarditis to receive a viral vector-based vaccine prior history to vaccine-induced immune thrombotic thrombocytopenia prior history of heparin-induced thrombocytopenia prior history of capillary leak syndrome